Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Systemic Sclerosis with Rituximab: Evaluation of the Effectiveness of B-cell Depletion Therapy
2012-004955-35Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- May 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing Rituximab with Placebo (2 arms). Primary endpoint: Change in Rodnan skin score. Started May 2013; status: completed.
02
Drugs
rituximab
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2012-004955-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004955-35.